Parenteral Lipid-Based Nanoparticles for CNS Disorders: Integrating Various Facets of Preclinical Evaluation towards More Effective Clinical Translation

Contemporary trends in combinatorial chemistry and the design of pharmaceuticals targeting brain disorders have favored the development of drug candidates with increased lipophilicity and poorer water solubility, with the expected improvement in delivery across the blood–brain barrier (BBB). The gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilić, Tanja, Đoković, Jelena B., Nikolić, Ines, Mitrović, Jelena R., Pantelić, Ivana, Savić, Snežana D., Savić, Miroslav M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966342/
https://www.ncbi.nlm.nih.gov/pubmed/36839768
http://dx.doi.org/10.3390/pharmaceutics15020443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966342/
https://www.ncbi.nlm.nih.gov/pubmed/36839768
http://dx.doi.org/10.3390/pharmaceutics15020443

Ejemplares similares